Influenzinum 2015-2016 (Energique, Inc.)
Welcome to the PulseAid listing for the Influenzinum 2015-2016 drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Energique, Inc. |
NON-PROPRIETARY NAME: | Influenzinum |
SUBSTANCE NAME: | INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-12-16 |
END MARKETING DATE: | 2021-01-26 |
Influenzinum 2015-2016 HUMAN OTC DRUG Details:
Item Description | Influenzinum 2015-2016 from Energique, Inc. |
LABELER NAME: | Energique, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200; 200; 200; 200; 200; 200([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL) |
START MARKETING DATE: | 2015-12-16 |
END MARKETING DATE: | 2021-01-26 |
PRODUCT ID: | 44911-0313_6f92f885-3688-4c32-bb74-c6f635653c68 |
PRODUCT NDC: | 44911-0313 |
APPLICATION NUMBER: | |
Other INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, Pharmaceutical Manufacturers / Labelers: